Pathophysiology of Aortic Stenosis and Future Perspectives for Medical Therapy

Kang H Zheng1, Evangelos Tzolos2, Marc R Dweck2

  • 1Department of Vascular Medicine, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

Cardiology Clinics
|November 23, 2019
PubMed

Insights

Calcific aortic valve stenosis is a growing health burden with no current medical treatments. This review explores new therapeutic targets like oxidized lipids, fibrosis, and calcification to slow disease progression.

Area of Science:

  • Cardiovascular Medicine
  • Valvular Heart Disease
  • Biomedical Research

Background:

  • Calcific aortic valve stenosis (CAVS) is the most prevalent heart valve disease in high-income nations.
  • Current treatment options for CAVS are limited to surgical aortic valve replacement, with uncertain optimal timing and patient suitability.
  • There is a significant unmet need for medical therapies to slow or halt the progression of CAVS.

Purpose of the Study:

  • To review the pathophysiology of aortic stenosis.
  • To discuss the role of noninvasive imaging in understanding CAVS biology.
  • To explore potential novel therapeutic strategies targeting key molecular pathways in CAVS.

Main Methods:

  • Literature review of pathophysiology and imaging techniques in aortic stenosis.
  • Analysis of emerging insights into the biological mechanisms of CAVS.
  • Discussion of potential translation of research findings into clinical treatments.

Main Results:

  • Aortic stenosis pathophysiology involves complex biological processes.
  • Noninvasive imaging has enhanced the understanding of underlying CAVS biology.
  • Emerging research identifies oxidized lipids, fibrosis, and calcification as potential therapeutic targets.

Conclusions:

  • Novel therapeutic approaches targeting specific molecular pathways may offer future treatment options for CAVS.
  • Further research is needed to translate these insights into effective medical therapies.
  • Addressing the burden of CAVS requires innovative treatment strategies beyond surgical intervention.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
336
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
205
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
405
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
350
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
226
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
238